BioCentury
ARTICLE | Clinical News

Synavive: Phase IIb started

July 4, 2011 7:00 AM UTC

Zalicus began the 12-week, double-blind, placebo-controlled, international Phase IIb SYNERGY trial to compare once-daily Synavive vs. monotherapy with once-daily prednisolone, once-daily dipyridamole ...